Mandrake Bio raises Rs 16 crore for AI-designed gene-editing tools
Official logo: Mandrake BioMandrake Bio combines generative AI and biophysics to design gene-editing enzymes for agriculture and potential medical applications. The Financial Express reports a Rs 16 crore pre-seed round co-led by Activate and Antler India, with other investors participating. The startup plans to expand its technical teams and laboratory validation rather than claim its designs are already approved treatments.
DTT summary based on The Financial Express's report. The full article is on the publisher's site.
Round details
Combines generative AI and biophysics to design gene-editing enzymes for agriculture and potential medical applications.
- Funding supports technical teams and laboratory validation.
- Enzyme designs are not established approved medical treatments.
- Pre-seed raised: ₹16 Cr
- Investors: Activate, Antler India